KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Johnson & Johnson (JNJ) R&D In Process (2016 - 2023)

Historic R&D In Process for Johnson & Johnson (JNJ) over the last 13 years, with Q2 2023 value amounting to $49.0 million.

  • Johnson & Johnson's R&D In Process fell 9196.72% to $49.0 million in Q2 2023 from the same period last year, while for Apr 2023 it was $222.0 million, marking a year-over-year decrease of 8529.8%. This contributed to the annual value of $783.0 million for FY2023, which is 1300.0% down from last year.
  • Johnson & Johnson's R&D In Process amounted to $49.0 million in Q2 2023, which was down 9196.72% from $173.0 million recorded in Q1 2023.
  • Johnson & Johnson's R&D In Process' 5-year high stood at $900.0 million during Q4 2021, with a 5-year trough of $6.0 million in Q2 2020.
  • Moreover, its 5-year median value for R&D In Process was $155.5 million (2020), whereas its average is $350.4 million.
  • In the last 5 years, Johnson & Johnson's R&D In Process skyrocketed by 55217.39% in 2021 and then plummeted by 9196.72% in 2023.
  • Johnson & Johnson's R&D In Process (Quarter) stood at $890.0 million in 2019, then plummeted by 84.49% to $138.0 million in 2020, then soared by 552.17% to $900.0 million in 2021, then crashed by 32.22% to $610.0 million in 2022, then tumbled by 91.97% to $49.0 million in 2023.
  • Its R&D In Process stands at $49.0 million for Q2 2023, versus $173.0 million for Q1 2023 and $610.0 million for Q2 2022.